Quick Answer
Emmaus Life Sciences, Inc. reported Long-Term Debt of $587.7 thousand for fiscal year 2018.
Emmaus Life Sciences, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2018 | $587.7K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| June 30, 2019 | $615.8K | +6.5% | +1.5% |
| March 31, 2019 | $606.5K | +6.6% | +1.6% |
| December 31, 2018 | $597.1K | +6.7% | +1.6% |
| September 30, 2018 | $587.7K | — | +1.6% |
| June 30, 2018 | $578.4K | — | +1.7% |
| March 31, 2018 | $569.0K | — | +1.7% |
| December 31, 2017 | $559.7K | — | +0.8% |
| October 31, 2017 | $555.0K | — | — |
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on December 11, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: